The clinical, genomic, and transcriptomic landscape of BRAF mutant cancers
S. Kazandjian, E. Rousselle, M. Dankner, D. W. Cescon, A. Spreafico, K. Ma, P. Kavan, G. Batist, A. A. N. Rose
This paper analyzes the clinical, genomic, and transcriptomic features of BRAF mutant cancers across multiple tumor types and identifies demographic and molecular differences between BRAF mutation classes.
bioRxiv · Sep 15, 2023Cancer Biology